跳至主要内容
临床试验/CTRI/2023/06/054256
CTRI/2023/06/054256尚未招募2 期

To develope and evaluate the efficacy of chaturajata taila inhaler in vataj pratishay with special reference to allergic rhinitis-a randomized controlled prospective clinical study

Dean Parul institute of ayurved1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年1月8日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
The patient will improve in nasasrav kshavathu shirashoola

研究概览

简要总结

Allergic rhinitis is very common diseases among all the age groups

Allergic rhinitis is not a serious illness, it is clinically relevant because it will cause many complications and affects qualitry of life, and productivity at school and work place

Nose is one of the most delicate and exposed organ of the body and it is the most common site for all allergic reactions

In modern medicine nasal sprays are the most effective treatment, but it comes with some limitations

This study aims at introducing a cost effective, easy to handle, easy to use nasal inhaler

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • Patient having symptoms of Vataj Pratishyay Age between 18-40yrs Those who give consent as per requirement.

排除标准

  • Patients with known case of hypertension, Diabetic mellitus, heart disease and bronchial asthma Patients presenting with complications of pratishyay like nasal polyps, tumour of nose, DNS, old fracture of nose.
  • If patients is suspected of COVID – 19 infection after scanning with respect to clinical signs & symptoms and history of patients, than he/she will be referred through proper channel for further treatment.
  • She/he will not be included in trial.

结局指标

主要结局

The patient will improve in nasasrav kshavathu shirashoola

时间窗: Day 8 | Day 15

次要结局

  • The patient will improve in nasaanaha(Day 8)

研究者

发起方
Dean Parul institute of ayurved
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验